Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).

---

Atıf İçin Kopyala

HIZAL M., ŞENDUR M. A. N., YAŞAR H. A., Bir Yucel K., Arslan C., Ucar G., ...Daha Fazla

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, cilt.26, sa.7, ss.1583-1589, 2020 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 26 Sayı: 7
• Basım Tarihi: 2020
• Doi Numarası: 10.1177/1078155219900908
• Dergi Adı: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
• Sayfa Sayıları: ss.1583-1589
• Anahtar Kelimeler: Interferon, neutrophil-lymphocyte ratio, prognosis, renal cell cancer, tyrosine kinase inhibitors, PRETREATMENT NEUTROPHIL, INFLAMMATION, CANCER, IMPACT, PROGRESSION, VALIDATION
• Gazi Üniversitesi Adresli: Evet

Özet

Background